STATIN USE IN PATIENTS WITH CORONARY ARTERY DISEASE AND DYSLIPIDEMIA: REVIEW OF RECENT CLINICAL GUIDELINES

Abstract

Statins are widely recommended for the management of patients with coronary artery disease (CAD) and dyslipidemia due to their proven efficacy in reducing LDL cholesterol levels and preventing adverse cardiovascular events. This study reviews the most recent clinical guidelines, including those published by the American College of Cardiology (ACC), American Heart Association (AHA), and European Society of Cardiology (ESC), to assess current recommendations for statin use in patients with CAD and dyslipidemia. The review revealed a strong consensus on the efficacy of statins in reducing cardiovascular risk, with most guidelines recommending high-intensity statin therapy for patients with CAD. However, guidelines vary in their approach to therapy intensity and combination with other lipid-lowering agents. Monitoring for adverse effects and personalization of therapy are emphasized to optimize clinical outcomes and minimize risks. The analysis also highlighted the need to balance efficacy and safety in the clinical application of statins.